Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy's Lombardy Region: A large population-based study

被引:39
作者
Baviera, Marta [1 ]
Monesi, Lara [1 ]
Marzona, Irene [1 ]
Avanzini, Fausto [1 ]
Monesi, Gabriella [2 ]
Nobili, Alessandro [3 ]
Tettamanti, Mauro [4 ]
Riva, Emma [4 ]
Cortesi, Laura [1 ]
Bortolotti, Angela [5 ]
Fortino, Ida [5 ]
Merlino, Luca [5 ]
Fontana, Giancarlo [5 ]
Roncaglioni, Maria Carla [1 ]
机构
[1] Mario Negri Inst Pharmacol Res, Lab Gen Practice Res, I-20156 Milan, Italy
[2] S Maria della Misericordia Hosp, Diabet Unit, Rovigo, Italy
[3] Mario Negri Inst Pharmacol Res, Lab Qual Assessment Geriatr Therapies & Serv, I-20156 Milan, Italy
[4] Mario Negri Inst Pharmacol Res, Unit Geriatr Pharmacol, I-20156 Milan, Italy
[5] Reg Hlth Minist, Milan, Italy
关键词
Diabetes mellitus; Prescribing trends; Antidiabetic drugs; Cardiovascular medications; GLYCEMIC CONTROL; PRESCRIBING TRENDS; MELLITUS; PREVALENCE; MORTALITY; HYPERTENSION; GUIDELINES; ADULTS; IMPACT;
D O I
10.1016/j.diabres.2011.05.004
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective: To analyze the prescribing patterns of antidiabetic and cardiovascular medications among diabetics in the most highly populated Italian Region, from 2000 to 2008. Methods: Data were obtained from the Lombardy Region administrative health databases. The standardized prevalence of antidiabetic and cardiovascular drugs use was calculated within each study year. The prescription trends of initial treatment with antidiabetic drugs were also analyzed. Results: From 2000 to 2008 there was an increase in the proportion of patients treated with biguanides (from 53.4% to 66.5%; p < 0.0001) while those receiving sulfonylurea decreased (from 78.6% to 56.4%; p < 0.0001). A sharp increase of metformin (as monotherapy) as initial treatment was also observed (from 15.2% to 48.8%; p < 0.0001). The percentage of patients receiving renin-angiotensin system inhibitors, lipid-lowering drugs and antiplatelets increased between 2000 and 2008, from respectively 45.1% to 63.3%, 13.6% to 43.2% and 21.6% to 40.9 (p < 0.0001). Multivariate analyses indicated that changes in prescriptions were statistically significant for both antidiabetic and cardiovascular drugs. Conclusion: This study documents progressive changes in the prescription of antidiabetic and cardiovascular drugs in accordance with guidelines. However, the use of metformin as first line therapy was still suboptimal and cardiovascular preventive strategies were only partially implemented in community practice. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 36 条
[1]
National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007 [J].
Alexander, G. Caleb ;
Sehgal, Niraj L. ;
Moloney, Rachael M. ;
Stafford, Randall S. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (19) :2088-2094
[2]
*AMD, 2007, STAND IT CUR DIAB ME
[3]
Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S12-S54
[4]
American Diabetes Association: Diagnosis and classification of diabetes mellitus, 2005, DIABETES CARE S1, V28, P537
[5]
[Anonymous], 2005, Global Guideline for Type 2 Diabetes
[6]
Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661
[7]
Under-prescribing of cardiovascular therapies for diabetes in primary care [J].
Bennett, KE ;
Williams, D ;
Feely, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 58 (12) :835-841
[8]
Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases [J].
Brocco, Stefano ;
Visentin, Cristiana ;
Fedeli, Ugo ;
Schievano, Elena ;
Avogaro, Angelo ;
Andretta, Margherita ;
Avossa, Francesco ;
Spolaore, Paolo .
CARDIOVASCULAR DIABETOLOGY, 2007, 6 (1)
[9]
*CINECA OSS, CINECA OSS ARNO DIAB, V11
[10]
Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes [J].
Cohen, FJ ;
Neslusan, CA ;
Conklin, JE ;
Song, X .
DIABETES CARE, 2003, 26 (06) :1847-1851